文献速递生殖医学

复杂染色体易位携带者及双方均携带染色体易位的夫妇接受胚胎植入前遗传学检测的临床结局

Clinical outcomes of complex chromosomal rearrangement carriers and couples both harbouring chromosomal rearrangements who undergo preimplantation genetic testing.
PubMed 文献 · Reprod Biomed Online · 2025-01-25

本病例系列纳入8对非典型染色体易位夫妇(5例复杂染色体易位携带者及3对双方均携带染色体易位的夫妇),行囊胚滋养层活检及胚胎植入前遗传学检测。共获223枚卵母细胞,获33枚囊胚(14.8%),其中整倍体5枚(15.1%)、嵌合体2枚(6.1%)、非整倍体26枚(78.8%)。移植4枚整倍体胚胎和1枚嵌合体胚胎,均未获得妊娠。

要点

  • 复杂染色体易位携带者产生非整倍体胚胎概率高,胚胎植入前遗传学检测效用低。
  • 双方均携带染色体易位的夫妇可获得合理比例的可移植胚胎,可能从胚胎植入前遗传学检测中获益。
  • 移植4枚整倍体胚胎和1枚嵌合体胚胎后均未获得妊娠。

核心结论

  • 复杂染色体易位携带者产生非整倍体胚胎概率高,胚胎植入前遗传学检测对其效用低,因此提倡精子/卵子捐赠体外受精。
  • 双方均携带染色体易位的夫妇可获得合理比例的可移植胚胎,可能从胚胎植入前遗传学检测中获益。

研究设计与样本

  • 本病例系列纳入8对非典型染色体易位夫妇,包括5例复杂染色体易位携带者和3对双方均携带染色体易位的夫妇,均行囊胚滋养层活检及胚胎植入前遗传学检测,并记录移植的临床结局。

主要发现

  • 8例参与者共获223枚卵母细胞,其中复杂染色体易位携带者157枚,双方均携带染色体易位的夫妇66枚。
  • 共获33枚囊胚(14.8%),其中整倍体5枚(15.1%)、嵌合体2枚(6.1%)、非整倍体26枚(78.8%)。
  • 复杂染色体易位携带者获整倍体、嵌合体和非整倍体囊胚分别为3枚、0枚和21枚;双方均携带染色体易位的夫妇分别为2枚、2枚和5枚。
  • 成功移植4枚整倍体胚胎和1枚嵌合体胚胎,但均未获得妊娠。

临床怎么用

  • 作者认为复杂染色体易位携带者胚胎植入前遗传学检测效用低,提倡精子/卵子捐赠体外受精。
  • 作者认为双方均携带染色体易位的夫妇可能从胚胎植入前遗传学检测中获益。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What are the clinical outcomes for carriers of complex chromosomal rearrangements (CCR) and couples with both partners harbouring chromosomal rearrangements who undergo preimplantation genetic testing (PGT)? DESIGN: This case series included eight couples with atypical chromosomal rearrangements (five CCR carriers and three couples with both partners harbouring chromosomal rearrangements) who underwent blastocyst trophectoderm biopsy as well as PGT. The clinical outcomes of the transfers were recorded. RESULTS: PGT was performed on eight carriers of atypical chromosomal rearrangements. A total of 223 oocytes (157 from CCR carriers and 66 from couples where both partners harboured chromosomal rearrangements) were retrieved from the eight participants. Thirty-three (14.8%) blastocysts were obtained, of which 5 (15.1%) were euploid, 2 (6.1%) were mosaic and the remaining 26 (78.8%) were aneuploid. For CCR carriers, there were 3, 0 and 21 euploid, mosaic and aneuploid blastocysts, respectively, and for couples where both partners harboured chromosomal rearrangements there were 2, 2 and 5. Four euploid embryos and one mosaic embryo were successfully transferred, but none of them produced a pregnancy. CONCLUSIONS: Carriers of atypical chromosomal rearrangements had a high probability of creating aneuploid embryos, and therefore PGT showed a low usefulness for CCR carriers. Thus, spermatozoa/egg donation IVF was advocated. Couples with both partners harbouring chromosomal rearrangements had a reasonable rate of transferable embryos and may benefit from PGT.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Lyu Z, Wang Y, Zhu X, et al. Clinical outcomes of complex chromosomal rearrangement carriers and couples both harbouring chromosomal rearrangements who undergo preimplantation genetic testing. Reprod Biomed Online. 2025. PMID: 40413851. doi:10.1016/j.rbmo.2025.104841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。